regulatory and reimbursement issues for medical devices in Medicare
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Duration: February 6, 2007
to
December 31, 2010
General Issues: Medicare/Medicaid , Taxation/Internal Revenue Code , Health Issues , Consumer Issues/Safety/Protection , Copyright/Patent/Trademark , Medical/Disease Research/Clinical Labs
Spending: about $475,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate, White House Office, Y
Y
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2010
RICCHETTI INCORPORATED terminated an engagement in which they represented Boston Scientific Corporation on Jan. 20, 2011.
Original Filing: 300354000.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
3rd Quarter, 2010
In Q3, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on Oct. 20, 2010.
Original Filing: 300328080.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
transparency of medical device pricing
issues relating to disclosure of payments to physicians and gift bans
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
2nd Quarter, 2010
In Q2, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on July 20, 2010.
Original Filing: 300297601.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
transparency of medical device pricing
issues relating to disclosure of payments to physicians and gift bans
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
issues related to excise taxes on medical device manufacturers in HR 3590, the Patient Protection and Affordable Care Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on June 8, 2010.
Original Filing: 300279940.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
transparency of medical device pricing
issues relating to disclosure of payments to physicians and gift bans
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
issues related to excise taxes on medical device manufacturers
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on Jan. 20, 2010.
Original Filing: 300246532.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
transparency of medical device pricing
issues relating to disclosure of payments to physicians and gift bans
issues affecting health care device manufacturers in HR 3590, the Patient Protection and Affordable Care Actissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
issues related to excise taxes on medical device manufacturers
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on Oct. 19, 2009.
Original Filing: 300210018.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
S. 2029 Physician Payments Sunshine Act
transparency medical device pricing
issues relating to disclosure of payments to physicians and gift bansissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Lobbying Issues
issues related to excise taxes on medical device manufacturers
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2009
In Q2, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on July 14, 2009.
Original Filing: 300177174.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
S. 2029 Physician Payments Sunshine Act
transparency medical device pricing
issues relating to disclosure of payments to physicians and gift bansissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
1st Quarter, 2009
In Q1, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $50,000. The report was filed on April 17, 2009.
Original Filing: 300154879.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
S. 2029 Physician Payments Sunshine Act
transparency medical device pricing
issues relating to disclosure of payments to physicians and gift bansissues relating to comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office
4th Quarter, 2008
In Q4, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $20,000. The report was filed on Jan. 13, 2009.
Original Filing: 300117037.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
S. 631 (Remote Monitoring Access Act of 2007)
S. 2029 Physician Payments Sunshine Act
S. 221 Transparency Medical Device Pricing Actcomparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
issues relating to the implementation of MDUFMA
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $20,000. The report was filed on Oct. 17, 2008.
Original Filing: 300097059.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
Medicare payments for inpatient hospital services
S. 631 (Remote Monitoring Access Act of 2007)
Medicare clinical research policyS. 2029 Physician Payments Sunshine Act
S. 221 Transparency Medical Device Pricing Act
comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1494 Pediatric Medical Device Safety and Improvement Act of 2007
issues relating to disclosure of payments to providers
issues relating to the implementation of MDUFMA
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $20,000. The report was filed on July 11, 2008.
Original Filing: 300063877.xml
Lobbying Issues
regulatory and reimbursement issues for medical devices in Medicare
Medicare payments for inpatient hospital services
S. 631 (Remote Monitoring Access Act of 2007)
Medicare clinical research policyS. 2029 Physician Payments Sunshine Act
S. 221 Transparency Medical Device Pricing Act
comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1494 Pediatric Medical Device Safety and Improvement Act of 2007
issues relating to disclosure of payments to providers
issues relating to the implementation of MDUFMA
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $15,000. The report was filed on April 17, 2008.
Original Filing: 300040876.xml
Lobbying Issues
Regulatory and reimbursement issues for medical devices in Medicare
Implementation of coverage, coding and reimbursement under the 2003 Medicare Prescription Drug Improvement and Modernization Act
HR 3162 Children's Health and Medicare Protection Act of 2007Medicare payment of inpatient hospital services
S. 631 Remote Monitoring Access Act of 2007
Medicare clinical research policy
S. 2029 Physician Payments Sunshine Act
S. 2221 Transparency Medical Device Pricing Act
comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1494 Pediatric Medical Device Safety and Improvement Act of 2007
Issues relating to disclosure of payments to providers
Issues relating to the implementation of MDUFMA
Issues relating to CHAMP Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
issues related to FDA medical device user fees
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2007
RICCHETTI INCORPORATED filed a lobbying registration on Feb. 19, 2007 to represent Boston Scientific Corporation, effective Feb. 6, 2007.
Original Filing: 200033933.xml
Issue(s) they said they’d lobby about: Issues related to FDA medical device user fees
Issues related to Medicare reimbursement for certain medical devices .
0th Quarter, 2007
In MM, RICCHETTI INCORPORATED lobbied for Boston Scientific Corporation , earning $75,000. The report was filed on Aug. 1, 2007.
Original Filing: 200043673.xml
Lobbying Issues
issues relating to FDA medical device user fees
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
Issues related to Medicare reimbursement for certain medical devices
Issues related to Medicare coverage of remote monitoring services
Lobbying Issues
Issues relating to the reauthorization of MDUFMA (FDA Amendments Act, HR 2900 and S 1082)
Issues relating to CHAMP Act (HR 1535, S. 895)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate